Application of adipose tissue-derived stem cells obtained by liposuction in tissue engineering
Public support
Provider
Ministry of Health
Programme
Programme to support medical applied research in 2015 to 2022
Call for proposals
Zdravotnický AV 1 (SMZ0201501)
Main participants
Fakultní nemocnice Bulovka
Contest type
VS - Public tender
Contract ID
15-33018A
Alternative language
Project name in Czech
Využití kmenových buněk tukové tkáně získané liposukcí v tkáňovém inženýrství
Annotation in Czech
Kmenové buňky získané liposukcí z tukové tkáně pacientů budou v tomto mezioborovém projektu využity k inženýrství bioarteficiální kostní, cévní a kožní tkáně. Nejprve budou vypracovány podmínky liposukce (především lokální anestézie, negativní tlak) optimální pro získání vysokého počtu životaschopných kmenových buněk. Tyto buňky budou dále vhodnými kultivačními podmínkami diferencovány směrem k osteoblastům a cévním hladkým svalovým buňkám, cévním endotelovým buňkám a keratinocytům. Kultivační podmínky budou zahrnovat: (i) nosič buněk z „umělého“ materiálu s vhodnými fyzikálně-chemickými vlastnostmi, jako je např. tuhost, deformabilita, smáčivost, náboj a vodivost, drsnost, morfologie, povrchová chemická struktura, 2D či 3D struktura, (ii) složení kultivačního média, (iii) mechanickou stimulaci v dynamickém bioreaktoru a (iv) elektrickou stimulaci. Diferencované buňky budou využity ke konstrukci hybridních náhrad kostní tkáně, cév a kůže. Tyto konstrukty budou obsahovat materiál nejvhodnější pro danou aplikaci a buněčnou složku, a budou perspektivní pro budoucí klinické aplikace.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
EA - Morphology and cytology
CEP - another secondary branch
FJ - Surgery including transplantology
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10601 - Cell biology<br>10602 - Biology (theoretical, mathematical, thermal, cryobiology, biological rhythm), Evolutionary biology<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30212 - Surgery<br>30213 - Transplantation<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
This project falls into the area of tissue engineering and regenerative medicine. Five independent teams with expertise covering clinical medicine, cell biology, and material engineering joint their forces and produced a plethora of very diverse results, for example technologies for isolation of stromal cells from lipoaspirate and their further differentiation towards clinically relevant cell types, instruments to study cells and to manipulate cells ex vivo, and physically and chemically modified materials to be applied in tissue engineering. All achievements of this project are of high scientific and medical significance as documented by many publications in high visibility journals, chapters in books, and also functional instruments. The application potential of the results obtained by this project is excellent. Diploma and doctoral theses were also produced based on this project. The project was solved in consonance with agency rules.
Solution timeline
Realization period - beginning
May 1, 2015
Realization period - end
Dec 31, 2018
Project status
U - Finished project
Latest support payment
Jun 28, 2018
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP19-MZ0-NV-U/01:1
Data delivery date
Jun 28, 2019
Finance
Total approved costs
20,278 thou. CZK
Public financial support
20,278 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK